FR173657
FR173657 is an orally active bradykinin B2 receptor antagonist (IC50: 0.56, 1.5, 2.9 nM for pig, rat, human B2 receptor respectively) . FR173657 (p.o.) inhibits BK-induced bronchoconstriction in guinea-pigs (ED50: 0.075 mg/kg) . FR173657 (p.o.) also inhibits Carrageenin-induced paw oedema in mice (ED50: 6.8 mg/kg) . FR173657 can be used for research of inflammatory disease[1].
Product Specifications
CAS Number
167838-64-4
Product Name Alternative
FK-3657
UNSPSC
12352005
Target
Bradykinin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/fr173657.html
Solubility
10 mM in DMSO
Smiles
O=C(NCC(N(C1=CC=C(Cl)C(COC2=C3N=C(C)C=CC3=CC=C2)=C1Cl)C)=O)/C=C/C4=CC=C(NC(C)=O)N=C4
Molecular Formula
C30H27Cl2N5O4
Molecular Weight
592.47
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Human Uncharacterized protein CYorf15A, CYorf15A ELISA Kit
Human Uncharacterized protein CYorf15A, CYorf15A ELISA Kit
Human Uncharacterized protein CYorf15A, CYorf15A ELISA Kit
Human Uncharacterized protein CYorf15A, CYorf15A ELISA Kit